Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proellex for Symptomatic Uterine Fibroids (ZPU-305)
NCT00737282Phase 3Terminated
- Sponsor
- Repros Therapeutics Inc.
- Start
- Oct 2008
- Primary completion
- Aug 2009
- Countries
- 1
01
Overview
A Phase 3 trial of telapristone in Uterine Fibroids (UF), sponsored by Repros Therapeutics Inc.. Started Oct 2008; status: terminated.
02
Drugs
telapristone
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT00737282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00737282.